Eterna Therapeutics
ERNA
#10112
Rank
โ‚ฌ8.94 M
Marketcap
0,17ย โ‚ฌ
Share price
3.88%
Change (1 day)
-91.96%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of April 2025 : 5.56

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 16.248.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-317.6475.7%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.48-55.37%๐Ÿ‡บ๐Ÿ‡ธ USA
3.39-39.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.05-154.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1.66-70.08%๐Ÿ‡ซ๐Ÿ‡ท France
4.41-20.76%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-45.55%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.06-45.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel